Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population

Neuroscience Letters

Volumn 489, Issue 2, 2011, Pages 126-130

  Nakataki, Masahito ^a   Iga, Jun ichi ^a   Numata, Shusuke ^a   Yoshimoto, Eriko ^a   Kodera, Kanami ^a   Watanabe, Shin ya ^a   Song, Hongwei ^a   Ueno, Shu ichi ^b   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Association analysis; Epithelial membrane protein 1 (EMP1); Expression analysis; Major depressive disorder; Single nucleotide polymorphism

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; EMP1 GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; JAPANESE; LEUKOCYTE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; JAPAN; LEUKOCYTES, MONONUCLEAR; MALE; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 78651414248     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.12.001     Document Type: Article

References (32)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 1997, American Psychiatric Association, Washington. 4th ed.
2. Baca-García E., Vaquero C., Diaz-Sastre C., Saiz-Ruiz J., Fernández-Piqueras J., de Leon J. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002, 26:692-695.
3. Bangsow T., Baumann E., Bangsow C., Jaeger M.H., Pelzer B., Gruhn P., Wolf S., von Melchner H., Stanimirovic D.B. The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier. J. Cereb. Blood Flow Metab. 2008, 28:1249-1260.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Bauman A.L., Goehring A.S., Scott J.D. Orchestration of synaptic plasticity through AKAP signaling complexes. Neuropharmacology 2004, 46:299-310.
6. Ben-Porath I., Benvenisty N. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene 1996, 183:69-75.
7. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., Milanesi E., Placentino A., Gennarelli M. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int. J. Neuropsychopharmacol. 2010, 13:103-108.
8. Chen Y., Medvedev A., Ruzanov P., Marvin K.W., Jetten A.M. cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 1997, 41:40-48.
9. Davis R.L., Cherry J., Dauwalder B., Han P.L., Skoulakis E. The cyclic AMP system and Drosophila learning. Mol. Cell. Biochem. 1995, 149-150:271-278.
10. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatr. 2006, 59:1116-1127.
11. Faul F., Erdfelder E., Lang A., Buchner A. GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Method 2007, 39:175-191.
12. Fernandes B.S., Gama C.S., Kauer-Sant'Anna M., Lobato M.I., Belmonte-de-Abreu P., Kapczinski F. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J. Psychiatr. Res. 2009, 43:1200-1204.
13. Gladkevich A., Kauffman H.F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2004, 28:559-576.
14. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., Chiba S., Noguchi H., Suzuki T., Iwata N., Ozaki N., Taguchi T., Kamiya A., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Sawa A., Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum. Mol. Genet. 2006, 15:3024-3033.
15. Jain A., Tindell C.A., Laux I., Hunter J.B., Curran J., Galkin A., Afar D.E., Aronson N., Shak S., Natale R.B., Agus D.B. Epithelial membrane protein-1 is a biomarker of gefitinib resistance. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11858-11863.
16. Kersting A., Kroker K., Horstmann J., Baune B.T., Hohoff C., Mortensen L.S., Neumann L.C., Arolt V., Domschke K. Association of MAO-A variant with complicated grief in major depression. Neuropsychobiology 2007, 56:191-196.
17. Lamprecht R. CREB: a message to remember. Cell. Mol. Life Sci. 1999, 55:554-563.
18. Lee B., Kim Y. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide. J. Affect Disord. 2010, 554-563.
19. Leonard B.E. The immune system, depression and the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2001, 25:767-780.
20. Levinson D.F. The genetics of depression: a review. Biol. Psychiatr. 2006, 60:84-92.
21. Li Y., Xue T., Wang L., Xu Z., Xi Z., Yuan J., Wang X., Chen Y., Zhang M., Yao L. Up-regulation of epithelial membrane protein-1 in the temporal neocortex of patients with intractable epilepsy. Neurochem. Res. 2009, 34:1594-1602.
22. Marvin K.W., Fujimoto W., Jetten A.M. Identification and characterization of a novel squamous cell-associated gene related to PMP22. J. Biol. Chem. 1995, 270:28910-28916.
23. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H.R., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
24. Numata S., Iga J., Nakataki M., Tayoshi S., Taniguchi K., Sumitani S., Tomotake M., Tanahashi T., Itakura M., Kamegaya Y., Tatsumi M., Sano A., Asada T., Kunugi H., Ueno S., Ohmori T. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:527-534.
25. Padmos R.C., Hillegers M.H.J., Knijff E.M., Vonk R., Bouvy A., Staal F.J.T., de Ridder D., Kupka R.W., Nolen W.A., Drexhage H.A. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatr. 2008, 65:395-407.
26. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Zhang H., Pavuluri M.N. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2010.
27. Schachner M., Martini R. Glycans and the modulation of neural-recognition molecule function. Trends Neurosci. 1995, 18:183-191.
28. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatr. 2008, 64:527-532.
29. Snipes G.J., Suter U., Shooter E.M. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 1993, 61:1961-1964.
30. Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B:261-268.
31. Tsai S., Gau Y.A., Hong C., Liou Y., Yu Y.W., Chen T. Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients. J. Affect Disord. 2009, 113:183-187.
32. Wulf P., Suter U. Embryonic expression of epithelial membrane protein 1 in early neurons. Brain Res. Dev. Brain Res. 1999, 116:169-180.